id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-D-0008-0004,FDA,FDA-2001-D-0008,FDA,Notice,NAD-Notice of Availability of Data,2006-10-20T04:00:00Z,2006,10,2006-10-19T04:00:00Z,2007-10-20T03:59:59Z,2008-04-25T02:25:09Z,,0,0,09000064804b45d8
FDA-2001-D-0008-0002,FDA,FDA-2001-D-0008,Guidance,Supporting & Related Material,GDL-Guidance,2006-10-20T04:00:00Z,2006,10,,,2008-04-25T02:25:09Z,,0,0,09000064804b45d2
FDA-2001-D-0008-0003,FDA,FDA-2001-D-0008,Guidance for Industry; Biological Product Deviation Reporting for Licensed Manufacturers of Biological Products Other than Blood and Blood Components,Other,Guidance,2006-10-01T04:00:00Z,2006,10,2006-10-01T04:00:00Z,,2024-11-07T21:53:11Z,,1,0,09000064804b45d5
FDA-2001-D-0008-0001,FDA,FDA-2001-D-0008,FDA,Notice,NAD-Notice of Availability of Data,2001-08-13T04:00:00Z,2001,8,2001-08-13T04:00:00Z,2001-11-14T04:59:59Z,2008-04-25T02:25:09Z,,0,0,09000064804b4545